Skip to main content

ACR/ARP 2019

2019 ACR/ARP Annual Meeting Highlights

Including news and expert commentaries on the NORDSTAR, RITAZAREM and SELECT-AXIS 1 trials.

Key clinical trials from ACR/ARP 2019

Expert interviews from ACR/ARP 2019

Sangeeta Sule

14-11-2019 | Juvenile idiopathic arthritis | Video | Article

Expert commentary: Safety and efficacy of tofacitinib in juvenile idiopathic arthritis

Sangeeta Sule gives a pediatric rheumatologist’s view on a trial looking at tofacitinib for the treatment  of polyarticular juvenile idiopathic arthritis and the potential implementation of the results in the clinic (2:55).

Irene van der Horst-Bruinsma

11-11-2019 | Axial spondyloarthritis | Video | Article

Researcher comment: The C-VIEW 48-week interim results

Irene van der Horst Bruinsma discusses the dual benefits of certolizumab pegol for patients with axial spondyloarthritis and a history of acute anterior uveitis (3:32).

More expert interviews from ACR/ARP 2019

More expert interviews from ACR/ARP 2019

Watch more interviews with researchers and independent experts on clinical trials presented at ACR/ARP 2019.

Research news from ACR/ARP 2019

19-11-2019 | Rheumatoid arthritis | ACR/ARP 2019 | News

Omega-3 supplements may benefit in RA patients

Taking omega-3 is associated with a reduction in measures of rheumatoid arthritis disease activity, suggests real-world data.

18-11-2019 | Systemic lupus erythematosus | ACR/ARP 2019 | Article

No benefit of add-on fenebrutinib for patients with SLE

Addition of the Bruton’s tyrosine kinase inhibitor fenebrutinib to standard care does not improve outcomes for patients with systemic lupus erythematosus, suggest findings from a phase II trial.

15-11-2019 | Systemic lupus erythematosus | ACR/ARP 2019 | News

Further investigation of telitacicept may be warranted for SLE

Telitacicept, a recombinant fusion protein targeting B-lymphocyte stimulator and the APRIL proliferation-inducing ligand, has shown potential for the treatment of systemic lupus erythematosus in a phase IIb trial conducted in China.

ACR/ARP 2019 pre-conference content

Key clinical trials at ACR/ARP 2019

Get up to speed on the clinical trials headlining ACR/ARP 2019 with our brief overviews.

Session recommendations

The Editorial and Advisory Board share their recommended sessions ahead of ACR/ARP 2019.

Medicine Matters conference coverage is brought to you in partnership with medwireNews